Skip to main content

Peer Review reports

From: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy

Original Submission
21 Apr 2017 Submitted Original manuscript
22 Aug 2017 Author responded Author comments - Kim Brogden
22 May 2017 Reviewed Reviewer Report - Massimo Barberis
18 Jul 2017 Reviewed Reviewer Report - Emilio Bria
Resubmission - Version 2
22 Aug 2017 Submitted Manuscript version 2
6 Oct 2017 Author responded Author comments - Kim Brogden
22 Sep 2017 Reviewed Reviewer Report - Massimo Barberis
30 Aug 2017 Reviewed Reviewer Report - Emilio Bria
Resubmission - Version 3
6 Oct 2017 Submitted Manuscript version 3
18 Jan 2018 Author responded Author comments - Kim Brogden
Resubmission - Version 4
18 Jan 2018 Submitted Manuscript version 4
4 Feb 2018 Author responded Author comments - Kim Brogden
Resubmission - Version 5
4 Feb 2018 Submitted Manuscript version 5
Publishing
15 Feb 2018 Editorially accepted
27 Feb 2018 Article published 10.1186/s12885-018-4134-y

You can find further information about peer review here.

Back to article page